CBX2 and breast cancer: CBX2 mRNA high expression was correlated to shorter RFS in BC patients with ER positive tumors (HR=1.69, p=1.3e-07) (Figure 4B), but not in ER negative tumors (HR=1.07, p=0.62) (Figure 4C).